Abstract
This study investigated the alterations of the 5-HT1A and 5-HT1B autoreceptor function following chronic treatment with fluvoxamine using osmotic minipumps. The 5-HT1A and 5-HT1B autoreceptor function were studied using microdialysis in the dorsal hippocampus. The effect of the 5-HT1A receptor agonist 8-OH-DPAT (0.3 mg/kg, SC) and the 5-HT1B receptor agonist RU-24969 (100 nM through the dialysis probe for 30 min) on 5-HT release was compared with rats chronically treated with saline. 8-OH-DPAT decreased 5-HT release to 55% and 60% of baseline, while RU-24969 decreased 5-HT release to 66% and 70% of baseline value in the saline and fluvoxamine group, respectively. In both cases, differences between the saline and fluvoxamine groups were not statistically significant. Plasma levels of fluvoxamine after 21 days of treatment ranged from 3 to 5 ng/ml. Fluvoxamine concentration in rat brain during treatment was estimated between 100 and 200 nM, which approximates to the IC50 value of fluvoxamine on the 5-HT transporter in synaptosomes and is 50 times higher than the Kd value for the 5-HT reuptake site. In conclusion, no evidence was found for changes in 5-HT1A,B receptor function using 8-OH-DPAT and RU-24969 as probes after continuous treatment with fluvoxamine by means of osmotic minipumps.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243–245
Blier P, de Montigny C (1987) Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470–480
Bonvento G, Scatton B, Claustre Y, Rouquier L, (1992) Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci Lett 137:101–104
Bosker FJ, Donker MG, Klompmakers AA, Kurata K, Westenberg HGM (1994) 5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: modulation by pindolol. Prog Neuro psychopharmacol Biol Psychiatry 18:765–778
Chaput Y, de Montigny C, Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of the 5-HT autoreceptors: electrophysiological studies in the rat. Naunyn-Schmiedebergs Arch Pharmacol 333:342–345
Chaput Y, Blier P, de Montigny C (1988) Acute and long-term effects of antidepressant serotonin (5-HT) reuptake blockers on the efficacy of 5-HT neurotransmission: electrophysiological studies in the rat central nervous system. Adv Biol Psychiatry 17:1–17
Chaput Y, de Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications of the serotonergic system by long-term administration of antidepressant treatments. Neuropsychopharmacology 5:219–229
Griebel G, Moreau JL, Jenck F, Misslin R, Martin JR (1994) Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmacology 113:463–470
Leonard BE (1992) Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance. Drugs 43:3–10
Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17:31–35
Malagie I, Jacquot C, Gardier AM (1992) In vivo release of scrotonin at fontocortical nerve terminals evoked by electrical stimulation of the dorsal raphe nucleus: effect of repeated administration of fluoxetine. Abstract 2nd International Symposium on Serotonin, Houston, p 47
Montero D, de Felipe MC, del Rio J (1991) Acute or chronic antidepressants do not modify125I-cyanopindolol binding to 5-HT1B receptors in rat brain. Eur J Pharmacol 196: 327–329
Moret C, Briley M (1990) Serotonin autoreceptor subsensitivity and antidepressant activity. Eur J Pharmacol 180: 351–356
Pandey SC, Isaac L, Davis JM, Pandey GN (1991) Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain. Eur J Pharmacol 202:221–225
Paxinos S, Watson C (1982) The rat brain in stereotoxic coordinates, Academic Press, New York
Santiago M, Westérink BHC (1990) Characterization of the in-vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn-Schmiedeberg's Arch Pharmacol 342:407–414
Schechter LE, Bolanos FJ, Gozlan H, Lanfumay L, Haj-Dahmane S, Laporte AM, Fattaccinic, Hamon M (1990) Alterations of central serotonergic and dopaminergic transmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. J Pharmacol Exp Ther 255:1335–1347
Sharp T, Bramwell SR, Grahame-Smith DG (1989a) 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96:283–290
Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG (1989b) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br J Pharmacol 98:989–997
Sharp T, Bramwell SR, Clark D, Grahame-Smith DG (1989c) In vivo measurements of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity. J Neurochem 53:234–240
Sleight AJ, Smith RJ, Marsden CA, Palfreyman MG (1989) The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo. Neuropharmacology 28:477–480
Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Harmon M (1990) Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 12:1144–1154
Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1:3–9
Welner SA, de Montigny C, Desorches J, Desjardins P, Suranyi-Cadotte BE (1989) Autoradiographic quantification of serotonin (5-HT1A) receptors following long-term antidepressant treatment. Synapse 4:347–352
Westenberg HGM, den Boer JA (1993) New findings in the treatment of panic disorder. Pharmacopsychiatry 26:30–33
Westenberg HGM, den Boer JA (1994) The neuropharmacology of anxiety: a review on the role of serotonin. In: Den Boer JA, Sitsen JM (eds) Handbook of depression and anxiety. Marcel Dekker, New York, pp 405–447
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bosker, F.J., van Esseveldt, K.E., Klompmakers, A.A. et al. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology 117, 358–363 (1995). https://doi.org/10.1007/BF02246110
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246110